Consensus Novartis AG

Equities

NOVN

CH0012005267

Real-time Estimate Cboe Europe 06:37:19 2023-09-22 am EDT			5-day change	1st Jan Change
91.96 ^CHF	-0.81%		-0.30%	+10.04%

12:27pm	NOVARTIS AG : Deutsche Bank gives a Buy rating	MD
07:00am	Big Pharma bets on AI to speed up clinical trials	RE

Evolution of the average Target Price on Novartis AG

Price target over the last 5 years

History : Analyst Recommendations

a3906579ab89746.rl9t6FM1ZMlpGa3c0xFKQzdBBEoUlBKKXmCkYdJZ8zY.72tV3RhSNZZebefv5SQmclR4Ux1lx0a-Cj_nEqUuy3rAGCC5FnQQuTpK4A~57e0ad78ff62acfb91bf7663be23df26

Analyst Recommendations on Novartis AG

NOVARTIS AG : Deutsche Bank gives a Buy rating	06:27am	MD
Fitch Assigns Rating to Bausch + Lomb's Secured Term Loan, Secured Bond; Up 1.4%	Sep. 11	MT
NOVARTIS AG : Deutsche Bank reiterates its Buy rating	Sep. 08	MD
NOVARTIS AG : Jefferies maintains a Buy rating	Sep. 05	MD
NOVARTIS AG : Deutsche Bank gives a Buy rating	Sep. 05	MD
NOVARTIS AG : Gets a Buy rating from Deutsche Bank	Aug. 31	MD
NOVARTIS AG : JP Morgan remains Neutral	Aug. 31	MD
NOVARTIS AG : Deutsche Bank reiterates its Buy rating	Aug. 15	MD
NOVARTIS AG : Barclays maintains a Sell rating	Aug. 10	MD
Wedbush Downgrades Chinook Therapeutics to Neutral From Outperform as Sale to Novartis Draws Closer; Keeps $42 Price Target	Aug. 08	MT
Bank Vontobel Lifts Price Target on Novartis, Maintains Buy Recommendation	Jul. 26	MT
AlphaValue/Baader Europe Lifts Price Target on Novartis, Maintains Add Recommendation	Jul. 25	MT
NOVARTIS : Healthy operating momentum pushes expectations higher	Jul. 25
DZ Bank AG Research Lowers Price Target on Novartis, Maintains Buy Recommendation	Jul. 20	MT
NOVARTIS AG : Deutsche Bank remains its Buy rating	Jul. 19	MD
NOVARTIS AG : JP Morgan reiterates its Neutral rating	Jul. 19	MD
NOVARTIS : Momentum sustained in Q2; another guidance upgrade	Jul. 18
NOVARTIS AG : UBS reiterates its Neutral rating	Jul. 18	MD
NOVARTIS AG : JP Morgan reiterates its Neutral rating	Jul. 18	MD
NOVARTIS AG : Gets a Buy rating from Jefferies	Jul. 18	MD
HSBC starts majority of pharma stocks with 'Buy' - Bayer, however, 'Reduce	Jul. 14	DP
NOVARTIS AG : Gets a Buy rating from Deutsche Bank	Jul. 10	MD
AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation	Jul. 06	MT
NOVARTIS AG : Jefferies remains its Buy rating	Jul. 05	MD
Fitch Maintains Novartis Rating on Strong Organic Growth	Jul. 03	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

102.65USD

Average target price

113.28USD

Spread / Average Target

+10.36%

High Price Target

129.45USD

Spread / Highest target

+26.11%

Low Price Target

89.43USD

Spread / Lowest Target

-12.88%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Novartis AG

DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
JEFFERIES	Peter Welford
JPMORGAN	Richard Vosser
BARCLAYS	Emily Field
Barrington Research
AlphaValue
DZ Bank
UBS	Michael Leuchten
Stifel Nicolaus
International Strategy & Investment Group
Credit Suisse
Morningstar
Kepler Capital Markets
ODDO BHF
GOLDMAN SACHS	Keyur Parekh
BERENBERG	Kerry Holford
DA Davidson
MORGAN STANLEY	Mark Purcell
Zacks Equity Research
BNP Paribas
Bank of America Securities/Merrill Lynch
BERNSTEIN RESEARCH	Wimal Kapadia
Kepler Cheuvreux
Wolfe Research
AltaCorp Capital
DEUTSCHE BANK	Emmanuel Papadakis
HSBC
Exane BNP Paribas
Bryan, Garnier & Co.
Berenberg Bank
Deutsche Bank Securities
Moody's Investors Service
Dundee
Exane BNP
Bernstein
Argus
Cowen
BRYAN GARNIER	Eric Le Berrigaud
LIBERUM CAPITAL	Graham Doyle
BANK OF AMERICA (BOFA)	Graham Parry

Ratings for Novartis AG

Trading Rating :

Investor Rating :

ESG Refinitiv :

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar